NIKKEI 225
39,911.20 +280.14 (+0.71%) HANG SENG
17,819.50 +100.89 (+0.57%) CRUDE OIL
83.54 +0.16 (+0.19%) GOLD FUTURES
2,336.40 -2.50 (-0.11%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,898.89 -156.86 (-0.31%)
SMMT Aug 2024 2.000 call
- Business Wire
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
MIAMI, June 27, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
- Zacks
Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
Summit Therapeutics (SMMT) surges after data from a late-stage study shows that its experimental antibody beat Merck's Keytruda in a head-to-head setting in treating certain patients with lung cancer.
- Business Wire
Summit Raises $200 Million; Also Expands License Territories for Ivonescimab
MIAMI, June 03, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the Company received and accepted an unsolicited offer from an institutional investor to purchase 22,222,222 shares of the Company’s common stock at $9.00 per share, a premium to the closing price on Friday, May, 31, 2024, for aggregate gross proceeds to the Company of approximately $200.0 million.
